http://www.dana-farber.org/Newsroom/News-Releases/olaparib-and-investigational-pi3k-inhibitor-bkm120-combination-active-against-ovarian-and-breast-cancer-subtypes.aspx
http://www.dana-farber.org/Newsroom/News-Releases/olaparib-and-investigational-pi3k-inhibitor-bkm120-combination-active-against-ovarian-and-breast-cancer-subtypes.aspx